Washington University School of Medicine is the medical school of Washington University in St. Louis in St. Louis, Missouri. Founded in 1891, the School of Medicine has 1,260 students, 604 of which are pursuing a medical degree with or without a combined Doctor of Philosophy or other advanced degree.

During the past decade, Washington University School of Medicine conducted 1632 clinical trials. In the 10-year time frame, 1632 clinical trials started and 946 clinical trials were completed, i.e. on average, 58% percent of trials that started reached the finish line to date. In the past 5 years, 720 clinical trials started and 533 clinical trials were completed. i.e. 74% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Washington University School of Medicine" #1 sponsor was "Washington University School of Medicine" with 838 trials, followed by "National Cancer Institute (NCI)" with 354 trials sponsored, "Children's Oncology Group" with 112 trials sponsored, "Gynecologic Oncology Group" with 65 trials sponsored and "Bristol-Myers Squibb" with 65 trials sponsored. Other sponsors include 1470 different institutions and companies that sponsored additional 581 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Washington University School of Medicine" #1 collaborator was "National Cancer Institute (NCI)" with 420 trials as a collaborator, "NRG Oncology" with 63 trials as a collaborator, "National Institutes of Health (NIH)" with 50 trials as a collaborator, "Washington University School of Medicine" with 49 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 43 trials as a collaborator. Other collaborators include 1406 different institutions and companies that were collaborators in the rest 670 trials.

According to Clinical.Site data, the most researched conditions in "Washington University School of Medicine" are "Multiple Myeloma" (58 trials), "Breast Cancer" (56 trials), "Obesity" (51 trials), "Acute Myeloid Leukemia" (40 trials) and "Ovarian Cancer" (37 trials). Many other conditions were trialed in "Washington University School of Medicine" in a lesser frequency.

Most popular intervention types in "Washington University School of Medicine" are "Drug" (1965 trials), "Other" (640 trials), "Biological" (444 trials), "Procedure" (398 trials) and "Device" (247 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (266 trials), "Laboratory Biomarker Analysis" (253 trials), "Quality-of-Life Assessment" (113 trials), "Carboplatin" (91 trials) and "Cyclophosphamide" (91 trials). Other intervention names were less common.

The vast majority of trials in "Washington University School of Medicine" are 2505 trials for "All" genders, 299 trials for "Female" genders and 95 trials for "Male" genders.

Currently, there are 1071 active trials in "Washington University School of Medicine". 21 are not yet recruiting, 516 are recruiting, 513 are Active, not recruiting, and 21 are Enrolling by invitation. In total, there were 1384 completed trials in Washington University School of Medicine, 22 suspended trials, and 331 terminated clinical trials to date.

Out of the total trials that were conducted in Washington University School of Medicine, 579 "Phase 1" clinical trials were conducted, 1091 "Phase 2" clinical trials and 676 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 68 trials, and there were also 392 trials that are defined as “Not Applicable".